Zobrazeno 1 - 10 of 67 pro vyhledávání: '"Vasen, H.F."'
1
No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies
Autor: Engel, C., Vasen, H.F., Seppala, T., Aretz, S., Bigirwamungu-Bargeman, M., Boer, S.Y. de, Bucksch, K., Buttner, R., Holinski-Feder, E., Holzapfel, S., Huneburg, R., Jacobs, M.A.J.M., Jarvinen, H., Kloor, M., Doeberitz, M.V., Koornstra, J.J., Kouwen, M. van, Langers, A.M., Meeberg, P.C. van de, Morak, M., Moslein, G., Nagengast, F.M., Pylvanainen, K., Rahner, N., Renkonen-Sinisalo, L., Sanduleanu, S., Schackert, H.K., Schmiegel, W., Schulmann, K., Steinke-Lange, V., Strassburg, C.P., Vecht, J., Verhulst, M.L., Cappel, W.D.T.N., Zachariae, S., Mecklin, J.P., Loeffler, M., German HNPCC Consortium, Dutch Lynch Syndrome, Finnish Lynch Syndrome Registry
Publikováno v: Gastroenterology, 155, 5, pp. 1400-1409.e2
Gastroenterology, 155(5), 1400-1409.e2. W.B. Saunders Ltd
Gastroenterology, 155, 1400-1409.e2
German HNPCC Consortium, the Dutch Lynch Syndrome Collaborative Group, and the Finnish Lynch Syndrome Registry 2018, ' No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies ', Gastroenterology, vol. 155, no. 5, pp. 1400-1409.e2 . https://doi.org/10.1053/j.gastro.2018.07.030
Gastroenterology, 155(5), 1400-+. W B SAUNDERS CO-ELSEVIER INC
Gastroenterology, 155(5), 1400
BACKGROUND & AIMS: Patients with Lynch syndrome are at high risk for developing colorectal cancer (CRC). Regular colonoscopic surveillance is recommended, but there is no international consensus on the appropriate interval. We investigated whether sh
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2ade3282dcf6a530ca9621dad024f6d
https://doi.org/10.1053/j.gastro.2018.07.030
Zobrazit plný text záznamu
2
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
Autor: Burn, J., Gerdes, A.M., Macrae, F., Mecklin, J.P., Moeslein, G., Olschwang, S., Eccles, D., Evans, D.G., Maher, E.R., Bertario, L., Bisgaard, M.L., Dunlop, M.G., Ho, J.W.C., Hodgson, S.V., Lindblom, A., Lubinski, J., Morrison, P.J., Murday, V., Ramesar, R., Side, L., Scott, R.J., Thomas, H.J.W., Vasen, H.F., Barker, G., Crawford, G., Elliott, F., Movahedi, M., Pylvanainen, K., Wijnen, J.T., Fodde, R., Lynch, H.T., Mathers, J.C., Bishop, D.T., CAPP2 Investigators
Publikováno v: Lancet (UK), 378(9809), 2081-2087. Elsevier Ltd.
Lancet, 378(9809), 2081-2087
Lancet
Burn, J, Gerdes, A-M, Macrae, F, Mecklin, J-P, Moeslein, G, Olschwang, S, Eccles, D, Evans, D G, Maher, E R, Bertario, L, Bisgaard, M-L, Dunlop, M G, Ho, J W C, Hodgson, S V, Lindblom, A, Lubinski, J, Morrison, P J, Murday, V, Ramesar, R, Side, L, Scott, R J, Thomas, H J W, Vasen, H F, Barker, G, Crawford, G, Elliott, F, Movahedi, M, Pylvanainen, K, Wijnen, J T, Fodde, R, Lynch, H T & Mathers, J C & Bishop, D T 2011, ' Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer : an analysis from the CAPP2 randomised controlled trial ', The Lancet, vol. 378, no. 9809, pp. 2081-7 . https://doi.org/10.1016/S0140-6736(11)61049-0
BACKGROUND: Observational studies report reduced colorectal cancer in regular aspirin consumers. Randomised controlled trials have shown reduced risk of adenomas but none have employed prevention of colorectal cancer as a primary endpoint. The CAPP2
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcc677a4a6000a0a30c9712ddbe3acd9
https://doi.org/10.1016/s0140-6736(11)61049-0
Zobrazit plný text záznamu
3
Variation in Mutation Spectrum Partly Explains Regional Differences in the Breast Cancer Risk of Female BRCA Mutation Carriers in the Netherlands
Autor: Vos, J.R., Teixeira, N., Kolk, D.M. van der, Mourits, M.J.E., Rookus, M.A., Leeuwen, F.E. van, Collee, M., Asperen, C.J. van, Mensenkamp, A.R., Ausems, M.G.E.M., Os, T.A.M. van, Meijers-Heijboer, H.E.J., Gomez-Garcia, E.B., Vasen, H.F., Brohet, R.M., Hout, A.H. van der, Jansen, L., Oosterwijk, J.C., Bock, G.H. de, Hereditary Breast Ovarian Canc Res
Publikováno v: Vos, J R, Teixeira, N, van der Kolk, DM, Mourits, M J E, Rookus, M A, van Leeuwen, F E, Collee, M, van Asperen, C J, Mensenkamp, A R, Ausems, M G E M, van Os, T A M, Meijers-Heijboer, H E J, Gomez-Garcia, E B, Vasen, HF, Brohet, R M, van der Hout, A H, Jansen, L, Oosterwijk, J C & de Bock, G H 2014, ' Variation in Mutation Spectrum Partly Explains Regional Differences in the Breast Cancer Risk of Female BRCA Mutation Carriers in the Netherlands ', Cancer Epidemiology Biomarkers and Prevention, vol. 23, no. 11, pp. 2482-2491 . https://doi.org/10.1158/1055-9965.EPI-13-1279
Cancer Epidemiology Biomarkers and Prevention, 23(11), 2482-2491. American Association for Cancer Research Inc.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 23(11), 2482-2491. AMER ASSOC CANCER RESEARCH
Cancer Epidemiology Biomarkers & Prevention, 23(11), 2482-2491. American Association for Cancer Research Inc.
Cancer epidemiology, biomarkers & prevention, 23(11), 2482-2491. American Association for Cancer Research Inc.
Cancer Epidemiology, Biomarkers & Prevention, 23, 11, pp. 2482-91
Cancer Epidemiology, Biomarkers & Prevention, 23, 2482-91
Cancer Epidemiology, Biomarkers and Prevention, 23(11), 2482-2491
Background: We aimed to quantify previously observed relatively high cancer risks in BRCA2 mutation carriers (BRCA2 carriers) older than 60 in the Northern Netherlands, and to analyze whether these could be explained by mutation spectrum or populatio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf6f5c7e61a378c24ce4b3e290bc5a98
https://research.vumc.nl/en/publications/85cf0125-54d5-41c4-8e9c-2d769ccf41c0
Zobrazit plný text záznamu
4
Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors
Autor: Rahner, N., Brockschmidt, F.F., Steinke, V., Kahl, P., Becker, T., Vasen, H.F., Wijnen, J.T., Tops, C.J., Holinski-Feder, E., Ligtenberg, M.J.L., Spruijt, L., Gorgens, H., Stemmler, S., Kloor, M., Dietmaier, W., Schumacher, J., Nothen, Markus, Propping, P., Hoogerbrugge, N.
Publikováno v: Familial Cancer, 11, 1, pp. 19-26
Familial Cancer, 11, 19-26
Familial Cancer, 11(1), 19-26
Familial Cancer, 11(1), 19-26. Springer, Cham
Item does not contain fulltext Lynch syndrome (Hereditary non-polyposis colorectal cancer/HNPCC) is a cancer susceptibility syndrome which is caused by germline mutations in DNA mismatch repair (MMR) genes, in particular MLH1 and MSH2. A pathogenic g
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36511faad563d6a4ee054c32b06da56a
https://hdl.handle.net/2066/108765
Zobrazit plný text záznamu
5
Body weight and risk of breast cancer in BRCA1/2 mutation carriers
Autor: Manders, P., Pijpe, A., Hooning, M.J., Kluijt, I., Vasen, H.F., Hoogerbrugge, N., Asperen, C.J. van, Meijers-Heijboer, H., Ausems, M.G., Os, T.A. van, Gomez-Garcia, E.B., Brohet, R.M., Leeuwen, F.E. van, Rookus, M.A., Ligtenberg, M.J.L.
Publikováno v: Breast Cancer Research and Treatment, 126(1), 193-202
Breast Cancer Research and Treatment, 126, 1, pp. 193-202
Breast Cancer Research and Treatment, 126(1), 193-202. Springer New York
Breast Cancer Research and Treatment, 126(1), 193-202. Springer, Cham
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, Springer Verlag, 2010, 126 (1), pp.193-202. ⟨10.1007/s10549-010-1120-8⟩
Breast Cancer Research and Treatment, 126(1), 193-202. SPRINGER
Breast Cancer Research and Treatment, 126, 193-202
Breast cancer research and treatment, 126(1), 193-202. Springer New York
Manders, P, Pijpe, A, Hooning, M J, Kluijt, I, Vasen, H F A, Hoogerbrugge, N, van Asperen, C J, Meijers-Heijboer, E J, Ausems, M G E M, van Os, T A M, Gomez-Garcia, E B, Brohet, R M, van Leeuwen, F E & Rookus, M A 2011, ' Body weight and risk of breast cancer in BRCA1/2 mutation carriers ', Breast Cancer Research and Treatment, vol. 126, no. 1, pp. 193-202 . https://doi.org/10.1007/s10549-010-1120-8
Contains fulltext : 95679.pdf (Publisher’s version ) (Closed access) Obesity is an established risk factor for postmenopausal breast cancer in the general population. However, it is still unclear whether this association also exists in BRCA1/2 muta
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d246d8fd176a3775aaa19c174c615530
http://hdl.handle.net/1887/109359
Zobrazit plný text záznamu
6
Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases
Autor: Hendriks, Y.M., Verhallen, J.T., Smagt, J.J. van der, Kant, S., Hilhorst, Y., Hoefsloot, L.H., Hansson, K.B., Straaten, P.J. van der, Boutkan, H., Breuning, M.H., Vasen, H.F., Brocker-Vriends, A.H.
Publikováno v: Familial Cancer, 2, 79-85
Familial Cancer, 2, 2, pp. 79-85
Item does not contain fulltext Bannayan-Riley-Ruvalcaba syndrome (BRRS) is characterised by macrocephaly, intestinal hamartomatous polyps, lipomas, pigmented maculae of the glans penis, developmental delay and mental retardation. The syndrome follows
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6511d842a16a1b9698cf64f0244caec6
http://hdl.handle.net/2066/121010
Zobrazit plný text záznamu
7
Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families
Autor: Vos tot Nederveen Cappel, W.H. de, Nagengast, F.M., Griffioen, G., Menko, F.H., Taal, B.G., Kleibeuker, J.H., Vasen, H.F.
Publikováno v: Diseases of the Colon and Rectum, 45, 1588-94
DISEASES OF THE COLON & RECTUM, 45(12), 1588-1594. LIPPINCOTT WILLIAMS & WILKINS
Diseases of the Colon and Rectum, 45, 12, pp. 1588-94
Item does not contain fulltext PURPOSE: Hereditary nonpolyposis colorectal cancer is caused by germline mutations in DNA mismatch repair genes. Mutation carriers have a 60 to 85 percent risk of developing colorectal cancer. In the Netherlands heredit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::461c0d676c90d209246c93d6b26991d5
http://hdl.handle.net/2066/185490
Zobrazit plný text záznamu
10
A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers
Autor: Vasen, H.F., Ballegooijen, M. van, Buskens, E., Kleibeuker, J.H., Taal, B.G., Griffioen, G., Nagengast, F.M., Menko, F.H., Meera Khan, P.
Publikováno v: Cancer, 82(9), 1632-1637. Wiley
Cancer, 82, 9, pp. 1632-1637
Cancer, 82, 1632-1637. John Wiley & Sons Inc.
Cancer, 82, 1632-1637
BACKGROUND. It has been estimated that the prevalence of carriers of a mutated mismatch repair (MMR) gene among the general population in Western countries is between 5 and 50 per 10,000. These carriers have a risk of >85% of developing colorectal ca
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b96e08d174da501113dc27dbfd91e540
https://research.rug.nl/en/publications/02286968-488e-46ec-86c6-4c65a1f501b4
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje